电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Lipoteichoic Acid 抗体

LTA 适用: Gram Positive Bacteria ELISA 宿主: 小鼠 Monoclonal 15711 unconjugated
产品编号 ABIN7232846
发货至: 中国
  • 抗原 See all Lipoteichoic Acid (LTA) 抗体
    Lipoteichoic Acid (LTA)
    适用
    Gram Positive Bacteria
    宿主
    • 4
    小鼠
    克隆类型
    • 4
    单克隆
    标记
    • 4
    This Lipoteichoic Acid antibody is un-conjugated
    应用范围
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    ELISA
    原理
    Anti-Lipoteichoic Acid Mouse Monoclonal Antibody
    特异性
    This antibody reacts with lipoteichoic acid of Staph epidermidis, Hay strain, as well as clinical strains of Staph. epidermidis (types I, II, and III), Staph. aureus strains 5 and 8, Strep. pyogenes, Strep. fecaelis, and Strep. mutans. It does not react with peptido- glycan of Staph. aureus or peptidoglycan- rhamnose, nor does it react with pneumococcal polysaccharides. This antibody does not cross-react with E. coli or H. influenzae type B.
    交叉反应
    Gram Positive Bacteria
    免疫原
    Staphylococcus epidermidis, Hay strain (ATCC #55133).
    克隆位点
    15711
    亚型
    IgG1
    Top Product
    Discover our top product LTA Primary Antibody
  • 应用备注
    ELISA: use at 0.1-1.0 μg/mL (optimized for LTA on solid phase).
    Opsonization assay: use at 80-160 μg/mL (optimized for Staph. epidermidis, Hay strain).
    限制
    仅限研究用
  • 状态
    Liquid
    溶解方式
    Dilute in PBS or medium that is identical to that used in the assay system.
    浓度
    Lot specific
    缓冲液
    PBS, pH 7.4
    储存条件
    -20 °C
    储存方法
    This antibody is stable for at least one (1) year at -20°C. Avoid multiple freeze-thaw cycles.
  • 抗原
    Lipoteichoic Acid (LTA)
    别名
    Lipoteichoic acid (LTA 产品)
    别名
    LT antibody, TNFB antibody, TNFSF1 antibody, lymphotoxin alpha antibody, LTA antibody
    物质类
    Chemical
    背景
    Lipoteichoic acid (LTA) is the major proinflammatory structure present within the cell wall layer of most gram-positive bacteria. It plays an important role in the initiation and progression of bacterial infection, inflammation, and septic shock. LTA induces several cytokines in vivo, and LTA and peptidoglycan (PepG) synergize to cause the induction of nitric oxide formation which can lead to multiple organ failure. Since LTA is also found in the cell walls of non-pathogenic gram-positive bacteria, it has been suggested that the structure of LTA , and its ability to synergize with PepG, determines the ability of a particular bacterium to cause septic shock.
You are here:
客服